166 related articles for article (PubMed ID: 37989845)
1. A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care.
Chang MM; Ma A; Novak EN; Barra M; Kundrod KA; Montealegre JR; Scheurer ME; Castle PE; Schmeler K; Richards-Kortum R
Sci Rep; 2023 Nov; 13(1):20397. PubMed ID: 37989845
[TBL] [Abstract][Full Text] [Related]
2. An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings.
Kundrod KA; Barra M; Wilkinson A; Smith CA; Natoli ME; Chang MM; Coole JB; Santhanaraj A; Lorenzoni C; Mavume C; Atif H; Montealegre JR; Scheurer ME; Castle PE; Schmeler KM; Richards-Kortum RR
Sci Transl Med; 2023 Jun; 15(701):eabn4768. PubMed ID: 37343083
[TBL] [Abstract][Full Text] [Related]
3. Single-tube four-target lateral flow assay detects human papillomavirus types associated with majority of cervical cancers.
Barra M; Chang M; Salcedo MP; Schmeler K; Scheurer M; Maza M; Lopez L; Alfaro K; Richards-Kortum R
Anal Biochem; 2024 May; 688():115480. PubMed ID: 38331373
[TBL] [Abstract][Full Text] [Related]
4. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
[TBL] [Abstract][Full Text] [Related]
5. Isothermal Method of a Recombinase Polymerase Amplification Assay for the Detection of Most Common High-Risk Human Papillomavirus Type 16 and Type 18 DNA.
Ma B; Fang J; Wang Y; He H; Dai M; Lin W; Su W; Zhang M
Clin Lab; 2017 Jan; 63(1):27-38. PubMed ID: 28164495
[TBL] [Abstract][Full Text] [Related]
6. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
7. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
Castle PE; Reid J; Dockter J; Getman D
J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
[TBL] [Abstract][Full Text] [Related]
8. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
Tao X; Zhang H; Zhang H; Xiao Y; Zhong F; Zhou X; Cong Q; Sui L; Zhao C
Cancer Cytopathol; 2022 Jul; 130(7):542-550. PubMed ID: 35312217
[TBL] [Abstract][Full Text] [Related]
9. Alinity m HR HPV Assay Fulfills Criteria for Human Papillomavirus Test Requirements in Cervical Cancer Screening Settings.
Oštrbenk Valenčak A; Šterbenc A; Seme K; Poljak M
J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31666369
[TBL] [Abstract][Full Text] [Related]
10. A low-cost, paper-based hybrid capture assay to detect high-risk HPV DNA for cervical cancer screening in low-resource settings.
Smith CA; Chang MM; Kundrod KA; Novak EN; Parra SG; López L; Mavume C; Lorenzoni C; Maza M; Salcedo MP; Carns JL; Baker E; Montealegre J; Scheurer M; Castle PE; Schmeler KM; Richards-Kortum RR
Lab Chip; 2023 Jan; 23(3):451-465. PubMed ID: 36562325
[TBL] [Abstract][Full Text] [Related]
11. WarmStart colorimetric LAMP for the specific and rapid detection of HPV16 and HPV18 DNA.
Daskou M; Tsakogiannis D; Dimitriou TG; Amoutzias GD; Mossialos D; Kottaridi C; Gartzonika C; Markoulatos P
J Virol Methods; 2019 Aug; 270():87-94. PubMed ID: 31042552
[TBL] [Abstract][Full Text] [Related]
12. Genotype distribution of cervical HPV among Caribbean women in a population-based study in Martinique: The DEPIPAPUFR study.
Najioullah F; Dorival MJ; Joachim C; Dispagne C; Macni J; Abel S; Sulpicy C; Charpentier-Baltide H; Sainte-Rose D; Salomon-Frechou B; Dieye M; Véronique-Baudin J; Pré M; Marquet M; Wan-Ajouhu G; Janky E; Riethmuller D; Cesaire R;
PLoS One; 2021; 16(10):e0257915. PubMed ID: 34618835
[TBL] [Abstract][Full Text] [Related]
13. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
[TBL] [Abstract][Full Text] [Related]
14. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
Marembo T; Dube Mandishora R; Borok M
Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
[TBL] [Abstract][Full Text] [Related]
15. HPV genotyping linear assay test comparison in cervical cancer patients: implications for HPV prevalence and molecular epidemiology in a limited-resource area in Bandung, Indonesia.
Panigoro R; Susanto H; Novel SS; Hartini S; Sahiratmadja E
Asian Pac J Cancer Prev; 2013; 14(10):5843-7. PubMed ID: 24289587
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening setting.
Oštrbenk Valenčak A; Bertram A; Gröning A; Poljak M
J Clin Virol; 2021 Jul; 140():104851. PubMed ID: 34020361
[TBL] [Abstract][Full Text] [Related]
17. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
18. HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.
Huijsmans CJ; Geurts-Giele WR; Leeijen C; Hazenberg HL; van Beek J; de Wild C; van der Linden JC; van den Brule AJ
BMC Cancer; 2016 Nov; 16(1):922. PubMed ID: 27894291
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
[TBL] [Abstract][Full Text] [Related]
20. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
[No Abstract] [Full Text] [Related]
[Next] [New Search]
